PROGEN.ST
Healthcare Diagnostics & ResearchProstatype Genomics AB (publ)
SEK 0.09
-0.00 -3.18% today
Price History
Not enough data
Key Stats
Market Cap
14.22M
Avg Volume
7.18M
EPS
-SEK 0.26
52W High
SEK 2.28
52W Low
SEK 0.09
Div. Yield
0.0%
Valuation
Forward P/E
-0.91
P/B Ratio
0.82
P/S Ratio
17.66
EV/EBITDA
-1.54
EV/Revenue
65.19
Margins
Gross Margin 0.0%
Operating Margin (4067.0%)
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Revenue Growth (YoY)
85.8%
Return on Equity
(176.2%)
Return on Assets
(55.9%)
Liquidity & Leverage
Current Ratio
0.04
Quick Ratio
0.04
Total Cash
392,000
Total Debt
0
About
Prostatype Genomics AB (publ) manufactures, markets, and sells prognostic gene tests. The company offers a Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, gleason score, RTqPCR kit, patient database and algorithms, Prostatype Web System (PWS), and tumor stage, as well as calculates the P-score. Its test is based on a database containing prostate cancer patients; and provides decision support for patients and doctors when making a treatment decision. The company was incorporated in 2007 and is headquartered in Nacka, Sweden.
www.prostatypegenomics.com